Improving Alzheimer's disease by altering gut microbiota in tree shrews with ginsenoside Rg1.

Limei Wang, Jiangli Lu, Yueqin Zeng, Yuqian Guo, Chao Wu, Hongbin Zhao, Hong Zheng, Jianlin Jiao

FEMS microbiology letters 2020 Feb 01

filter terms:

Ginsenoside Rg1 (GRg1) has neuroprotective effects on Alzheimer's disease (AD). The occurrence and progression of AD are closely related to gut microbiota. Few studies have learned the direct relationship between GRg1 and gut microbiota. In this study, we found an original way to research this relationship by using GRg1 in the AD model of tree shrews. Morris water maze and immunohistochemistry were performed to test the cognition repairing function of GRg1 by tree shrews and 16S ribosomal RNA sequencing was used to explore the composition and abundance of gut microbiota. After GRg1 treatment, the result of Morris water maze showed an improvement in cognitive function, and immunohistochemistry revealed a decrease in tau protein. Moreover, 16SrRNA sequencing results showed the abundances of Proteobacteria and Verrucomicrobia were significantly different, and Lactobacillaceae was significantly increased in the GRg1 treatment group. It also showed that the gut microbiome with middle and high doses of GRg1 was close to the normal group. In conclusion, this study suggests that GRg1 at middle and high doses may change the abundance of gut microbiota to improve AD, and thatProteobacteria and Verrucomicrobia are key microbiota. This is the first report that has ever studied the relationship between GRg1 and gut microbiota in tree shrews. © FEMS 2020.

Citation

Limei Wang, Jiangli Lu, Yueqin Zeng, Yuqian Guo, Chao Wu, Hongbin Zhao, Hong Zheng, Jianlin Jiao. Improving Alzheimer's disease by altering gut microbiota in tree shrews with ginsenoside Rg1. FEMS microbiology letters. 2020 Feb 01;367(4)